Search results for " asthma"

showing 10 items of 300 documents

Maximal degree of airway narrowing induced by methacholine and adenosine monophosphate: relationship with the decrease in forced vital capacity.

2010

Background Changes in forced vital capacity (FVC) may represent an indirect method for the detection of plateau in response to inhaled bronchoconstrictor agents. Objective To determine the relationship between the level of plateau obtained with either methacholine or adenosine monophosphate (AMP) and the decrease in FVC induced by each bronchoconstrictor agent. Methods Airway responsiveness to high concentrations of methacholine and AMP was determined in patients with intermittent asthma (n = 41) or allergic rhinitis (n = 26). Furthermore, allergen-induced changes in the response to each bronchoconstrictor agent were investigated in 18 pollen-sensitive patients. Concentration-response curve…

Pulmonary and Respiratory MedicineAdenosine monophosphateAdultMaleVital capacitymedicine.medical_specialtyRhinitis Allergic PerennialBronchoconstrictionImmunologyVital CapacityBronchial Provocation TestsBronchoconstrictor Agentschemistry.chemical_compoundFEV1/FVC ratioInternal medicineImmunology and AllergyMedicineHumansIn patientMethacholine Chloridebusiness.industryrespiratory systemIntermittent asthmaMiddle AgedConfidence intervalAdenosine MonophosphateAsthmarespiratory tract diseaseschemistryAnesthesiaCardiologyPollenMethacholineFemaleBronchial HyperreactivitybusinessAirwaycirculatory and respiratory physiologymedicine.drugAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observa…

2009

We conducted a large observational study in 193 children and adolescents with allergic rhinitis due to grass or tree pollens to evaluate the safety and tolerability of an ultrarush high-dose sublingual immunotherapy (SLIT) regimen reaching a maintenance dose of 300 index of reactivity within 90 minutes.Children and adolescents aged 5 to 17 years with at least a 1-year medical history of allergic rhinitis with or without mild to moderate asthma due to tree pollens (birch, alder, hazel) or grass pollens (cocksfoot, meadow grass, rye grass, sweet vernal grass, timothy) were recruited. Standardized grass and tree pollen allergen extracts were used for ultrarush titration and subsequent coseason…

MaleAdolescentAdministration SublingualPoaceaeAllergic rhinitisTreesHumansGrasses; Trees; Ultrarush; Sublingual immunotherapy; Children; Safety; Allergic rhinitis; AsthmaGrassesChildChildrenSublingual immunotherapyAntigens Plant; Trees; Immunotherapy; Humans; Asthma; Child; Pollen; Child Preschool; Poaceae; Rhinitis Allergic Seasonal; Seasons; Adolescent; Administration Sublingual; Female; MaleUltrarushRhinitis Allergic SeasonalAntigens PlantAsthmaChild PreschoolPollenFemaleSeasonsImmunotherapySeasonSafetyTreeHuman
researchProduct

La qualità dell’aria indoor: una priorità ambientale e sanitaria

2009

Tobacco Smoke Pollution; Multicenter Studies as Topic; Animals; Questionnaires; Air Pollution Indoor; Humans; Air Pollutants; Asthma; Child; Europe; Child Welfare; Italy; Life Style; Environmental Monitoring; World Health Organization; Respiratory Tract Diseases; Allergens; Cats; Dogs; Urban PopulationUrban PopulationAnimalQuestionnaireAllergenChild WelfareCatWorld Health OrganizationAsthmaEuropeItalyAir PollutantAir Pollution IndoorDogMulticenter Studies as TopicTobacco Smoke PollutionChildLife StyleRespiratory Tract DiseaseHumanEnvironmental Monitoring
researchProduct

Different skin prick test sensitization patterns do not influence the response to omalizumab in severe asthma

2017

Malemedicine.medical_specialtySevere asthmaSevere asthmaImmunologyEffectivenessOmalizumabOmalizumabSettore MED/10 - Malattie Dell'Apparato RespiratorioSeverity of Illness IndexmedicineHumansImmunology and AllergyAnti-Asthmatic AgentsSensitizationRetrospective StudiesSkin Testsbusiness.industryEffectiveneReal-lifeImmunoglobulin EEffectiveness; Omalizumab; Pollen sensitized; Real-life; Severe asthma; Immunology and Allergy; ImmunologyDermatologyAsthmaPollen sensitizedTest (assessment)Respiratory Function Testsmedicine.anatomical_structureTreatment Outcomeeffectiveness; omalizumab; pollen sensitized; real-life; severe asthmaFemaleImmunizationbusinessmedicine.drug
researchProduct

Factors that influence exhaled nitric oxide in Italian schoolchildren

2008

Conflicting results exist about the meaning of exhaled nitric oxide (eNO) in epidemiologic studies, mainly because of the numerous factors that may affect the measurement.To evaluate the role of the factors that influence eNO levels in a sample of schoolchildren with or without respiratory diseases. We studied 335 schoolchildren, ages 10 to 16 years, from 8 schools in Palermo, Italy. After a respiratory questionnaire was completed, spirometry, skin tests, and eNO measurements were performed.Among 335 children, 13.7% reported symptoms of bronchial asthma, 46.9% reported symptoms of rhinitis, and 39.4% were asymptomatic. The ratio of forced expiratory volume in 1 second to forced vital capaci…

Pulmonary and Respiratory MedicineSpirometryHypersensitivity ImmediateMalemedicine.medical_specialtyPediatricsVital capacityBreath TestAdolescentImmunologySex FactorNitric OxideAsymptomaticAtopySex FactorsInternal medicineSex Factors; Skin Tests; Exhalation; Humans; Asthma; Rhinitis; Child; Italy; Nitric Oxide; Cross-Sectional Studies; Spirometry; Allergens; Hypersensitivity Immediate; Adolescent; Breath Tests; Female; MalemedicineImmunology and AllergyHumansRespiratory systemChildSensitizationRhinitiAsthmaRhinitisSkin TestsCross-Sectional Studiemedicine.diagnostic_testSkin Testbusiness.industryAllergenAllergensmedicine.diseaseAsthmamedicine.anatomical_structureCross-Sectional StudiesBreath TestsItalyExhalationSpirometryExhaled nitric oxideFemalemedicine.symptombusinessHuman
researchProduct

A potential link between serum low-density lipoproteins and asthma

2015

Pulmonary and Respiratory MedicineHypersensitivity ImmediateMaleApolipoprotein A-Ibusiness.industryCholesterol HDLSettore MED/10 - Malattie Dell'Apparato RespiratorioCritical Care and Intensive Care Medicinemedicine.diseaseAsthmaText miningForced Expiratory VolumeImmunologyLow densityMedicineFemaleApolipoprotein A-I; Asthma; Cholesterol HDL; Female; Humans; Hypersensitivity Immediate; Male; Forced Expiratory VolumebusinessLink (knot theory)AsthmaHuman
researchProduct

Free Serum IgE In Patients With Severe Allergic Asthma Treated With Omalizumab

2010

business.industryImmunologyMedicineAllergic asthmaIn patientOmalizumabbusinessSerum igemedicine.drugD101. DIAGNOSIS AND TREATMENT OF ASTHMA
researchProduct

Paracetamol and antibiotics in childhood and subsequent development of wheezing/asthma: association or causation?

2011

Background Several studies found an association between early administration of paracetamol and antibiotics and development of wheezing. This could be due to confounding: wheeze and asthmatic symptoms in early childhood are difficult to distinguish from respiratory tract infections that are widely treated with these drugs; in case of persistence of symptoms up to school age, this could explain the observed relationship. Methods We investigated the association between paracetamol and antibiotics use in the first year of life and wheezing phenotypes, i.e. wheezing starting in different time periods (early, persistent and late-onset) in the SIDRIA-2 study, a cross-sectional survey of 16,933 ch…

MalePediatricsmedicine.medical_specialtyLogistic ModelAdolescentEpidemiologyCross-sectional studyRisk AssessmentFollow-Up StudieAge Distributionbias; causality; children; confounding factors; phenotypes; wheezingSurveys and QuestionnairesWheezeAnti-Bacterial AgentOdds RatiomedicineHumansAge of OnsetSex DistributionChildAcetaminophenRespiratory SoundsAsthmaCross-Sectional StudieRespiratory tract infectionsQuestionnairebusiness.industryIncidenceIncidence (epidemiology)Infant NewbornInfantGeneral MedicineOdds ratiomedicine.diseaseAsthmaConfidence intervalAnti-Bacterial AgentsCross-Sectional StudiesLogistic ModelsRespiratory Sounds; Odds Ratio; Questionnaires; Age of Onset; Humans; Infant Newborn; Asthma; Child; Italy; Risk Assessment; Age Distribution; Infant; Anti-Bacterial Agents; Cross-Sectional Studies; Logistic Models; Incidence; Follow-Up Studies; Adolescent; Sex Distribution; Male; Acetaminophen; FemaleItalyFemaleRespiratory Soundmedicine.symptomAge of onsetbusinessHumanFollow-Up StudiesInternational Journal of Epidemiology
researchProduct

Clinical evaluation and treatment of acute asthma exacerbations in children

2009

This update on treatment of asthma exacerbations in children is the result of an Italian Pediatric Society Task-force, made up of a panel of experts working in 2007–2008. The aim is to give clear indications on the use of the drugs most employed in children, grading the quality of evidence and the strength of recommendations. Suggestions on their limits due to unlicensed and off-label use are reported. The level of evidence and the strength of recommendations for different therapeutic approaches demonstrate that frequently the use of drugs in children is extrapolated from the experience in adults and that more studies are required to endorse the correct use of different drugs in asthmatic …

medicine.medical_specialtyImmunologyMEDLINESeverity of Illness Index; Acute Disease; Evidence-Based Medicine; Off-Label Use; Hospitalization; Humans; Treatment Outcome; Practice Guidelines as Topic; Asthma; Anti-Asthmatic Agents; Child; Child PreschoolOff-label useSeverity of Illness IndexSeverity of illnessHumansAnti-Asthmatic AgentImmunology and AllergyMedicineAnti-Asthmatic AgentsChildIntensive care medicineGrading (education)PharmacologyEvidence-Based MedicineAsthma exacerbationsbusiness.industryOff-Label UseEvidence-based medicineAsthmaHospitalizationQuality of evidenceacute asthma; children; emergency treatmentTreatment OutcomeSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAChild PreschoolAcute DiseasePractice Guidelines as Topicacute asthma exacerbations in childrenbusinessacute asthma exacerbations in children.Clinical evaluationHuman
researchProduct

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy

2017

Reslizumab, an anti-interleukin-5 monoclonal antibody, significantly reduces exacerbation frequency and improves lung function, asthma control and quality of life in adults with severe eosinophilic asthma, as demonstrated in Phase III studies. This secondary analysis assessed reslizumab's efficacy in patients receiving baseline treatment per Global Initiative for Asthma (GINA) Step 4 and Step 5 guidelines. Pooled data from duplicate, Phase III, reslizumab versus placebo studies in patients with severe eosinophilic asthma (blood eosinophils ≥400 cells·µL−1) were stratified by baseline therapy. Efficacy assessments were exacerbation rates and changes from baseline forced expiratory volume in …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbation2lcsh:MedicineEosinophilic asthmaPlacebo03 medical and health sciences0302 clinical medicineQuality of lifeReslizumabInternal medicineSecondary analysismedicineMedicine and Health Sciences030212 general & internal medicineLung functionAsthmabusiness.industrylcsh:ROriginal Articlesmedicine.diseaseSurgery030228 respiratory systembusinessmedicine.drugERJ Open Research
researchProduct